Towards Virtual Bioequivalence Studies for Oral Dosage Forms Containing Poorly Water-Soluble Drugs: A Physiologically Based Biopharmaceutics Modeling (PBBM) Approach-Reference-Cited by-同舟云学术

Towards Virtual Bioequivalence Studies for Oral Dosage Forms Containing Poorly Water-Soluble Drugs: A Physiologically Based Biopharmaceutics Modeling (PBBM) Approach

Published:2022-01 Issue:1 Volume:111 Page:135-145
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Kambayashi Atsushi,Dressman Jennifer B.

Funder

Astellas Pharma

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. Guidance for Industry: Immediate Release Solid Oral Dosage Forms: Scale-Up and Postapproval Changes,1995

2. Biopharmaceutics Classification System-Based Biowaivers (M9),2019

3. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies;Cristofoletti;J Pharm Sci,2013

4. Analysis of intra- and intersubject variability in oral drug absorption in human bioequivalence studies of 113 generic products;Sugihara;Mol Pharm,2015

5. Usage of in vitro metabolism data for drug-drug interaction in physiologically based pharmacokinetic (PBPK) analyses submissions to the U.S. Food and Drug Administration;Lee;J Clin Pharmacol,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based in vitro – in vivo correlation of modified release oral formulations with non-linear intestinal absorption: A case study using mirabegron;European Journal of Pharmaceutics and Biopharmaceutics;2024-11

2. Advancing Virtual Bioequivalence for Orally Administered Drug Products: Methodology, Real-World Applications and Future Outlook;Pharmaceuticals;2024-07-03

3. İLAÇLARDA SANAL BİYOEŞDEĞERLİK UYGULAMALARI;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-06-14

4. Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space;The AAPS Journal;2024-06-11

5. Mechanistic Modeling of In Vitro Biopharmaceutic Data for a Weak Acid Drug: A Pathway Towards Deriving Fundamental Parameters for Physiologically Based Biopharmaceutic Modeling;The AAPS Journal;2024-04-04